Literature DB >> 7005268

The diagnosis of Legionnaires' disease by counterimmunoelectrophoresis.

M G Holliday.   

Abstract

Counterimmunoelectrophoresis (CIE) was found to be a rapid, specific method for detecting circulating antibodies to Legionella pneumophila, the aetiologic agent of Legionnaires' disease in human sera. Optimum conditions for performing the test are given. Better precipitin lines are observed when the gel support is neutral, and a result may be obtained in 90 to 180 minutes. Comparison of results of CIE and indirect fluorescent antibody tests on 22 sera from patients with Legionnaires' disease and on 27 sera from healthy control subjects showed 100% correlation, and 75 paired sera from patients with pneumonia of unknown aetiology showed 96.7% correlation. Laboratory diagnosis may be made quickly and accurately by CIE. The method is simple and easily performed in the routine laboratory. The antigen is stable at 4 degrees C for at least six months.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005268      PMCID: PMC1146370          DOI: 10.1136/jcp.33.12.1174

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Four serogroups of Legionnaires' disease bacteria defined by direct immunofluorescence.

Authors:  R M McKinney; L Thacker; P P Harris; K R Lewallen; G A Hebert; P H Edelstein; B M Thomason
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

2.  Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine.

Authors:  K H Wong; W O Schalla; R J Arko; J C Bullard; J C Feeley
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

3.  The diagnosis of Legionnaires' disease.

Authors:  T F Tsai; D W Fraser
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

4.  Scottish experience with the serologic diagnosis of Legionnaires' disease.

Authors:  R J Fallon; W H Abraham
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

5.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

6.  Classification of the Legionnaires' disease bacterium: Legionella pneumophila, genus novum, species nova, of the family Legionellaceae, familia nova.

Authors:  D J Brenner; A G Steigerwalt; J E McDade
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

7.  Legionnaires' disease: clinical features of 24 cases.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

  7 in total
  4 in total

1.  Use of latex agglutination technique for detecting Legionella pneumophila (serogroup 1) antibodies.

Authors:  M G Holliday
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

2.  Counterimmunoelectrophoresis in the serodiagnosis of Legionnaires' disease.

Authors:  M Holliday
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

Review 3.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

4.  Agar microdroplet assay for delayed hypersensitivity to Legionella pneumophila serogroup 1.

Authors:  R Widen; T Klein; I Lee; H Friedman
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.